课题基金 / 基金详情

TAS::75 0849::TAS SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS PROGRAM

TAS::75 0849::TAS SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS PROGRAM
TAS::75 0849::TAS 监测、流行病学和最终结果计划
批准号:
8163638
负责人:
CHARLES LYNCH
金额:
$6.92万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-01 至 2011-09-29

项目摘要

项目成果

CHARLES LYNCH的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Surveillance, Epidemiology, and End Results (SEER) Program was established by the National Cancer Institute (NCI) to collect and report periodically on population-based cancer incidence and survival data. It is a core component of the NCI's surveillance activities which provide information used for planning cancer control and research programs, and for evaluating the impact of such programs on cancer rates. The SEER Program was initiated in 1972 in response to requirements of the National Cancer Program for assessing the magnitude of the cancer burden in the United States, and for identifying factors related to cancer risk and/or patient survival. Objectives of the SEER Program include: 1. Assemble and report, on a periodic basis, estimates of cancer incidence. 2. Monitor annual cancer incidence trends to identify unusual changes in specific forms of cancer occurring in population subgroups defined by geographic, demographic, and social characteristics. 3. Provide continuing information on changes over time in extent of disease at diagnosis, trends in therapy, and changes in cancer patient survival. 4. Identify the occurrence of possible iatrogenic cancers, i.e., cancers that are caused by cancer therapy. 5. Serve as a research resource to the National Cancer Institute, and conduct studies dealing with current cancer control issues as well as issues related to the operation of the SEER Program which may lead to improved and/or more cost-effective operating procedures.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NCI Patterns of Care (POC)/Quality of Care Study: Diagnosis Years 2017(NSCLC) and 2018 (NSCLC and Melanoma)
  • 批准号:
    10023787
  • 项目类别:
  • 资助金额:
    $7.13万
  • 财政年份:
    2019
  • 负责人:
    CHARLES LYNCH
  • 依托单位:
Surveillance, Epidemiology, and End Results (SEER) Program
  • 批准号:
    9926193
  • 项目类别:
  • 资助金额:
    $438.23万
  • 财政年份:
    2018
  • 负责人:
    CHARLES LYNCH
  • 依托单位:
Patterns of Care/Quality of Care Study: Diagnosis Year 2016
  • 批准号:
    9532315
  • 项目类别:
  • 资助金额:
    $5.19万
  • 财政年份:
    2017
  • 负责人:
    CHARLES LYNCH
  • 依托单位:
国内基金
海外基金
ProBDNF/p75NTR轴在肠缺血再灌注损伤中的神经-免疫调控作用
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    沈玮云
  • 依托单位:
IP3R/GRP75/VDAC1介导内质网应激—线粒体氧化应激调控慢传输型便秘ICC凋亡的机制及生血通便颗粒的干预作用
转录因子ZmbZIP75调控玉米籽粒成熟脱水的分子机制与育种应用研究
  • 批准号:
    2026JJ60400
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    龙田丹
  • 依托单位:
LRRC75A通过结合THRAP3调控ANXA1-ERK信号通路在结直肠癌增殖中的作用及机制研究
  • 批准号:
    2026JJ50308
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    梁纶熙
  • 依托单位: